Skip to content

Clinical trials

Completed Uterine Cervical Dysplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Dysplasia Status: Completed Clear all

209 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20021
20032
20048
20057
20068
20075
20086
200914
20109
201116
201210
20135
20149
201520
201611
201712
201813
20196
20208
20215
20225
20234
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed209

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline10
National Cancer Institute (NCI)9
Zydolab - Institute of Cytology and Immune Cytochemistry9
M.D. Anderson Cancer Center8
Ruhr University of Bochum5
Barretos Cancer Hospital4
British Columbia Cancer Agency4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Universiteit Antwerpen4
University of Aarhus4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Dysplasia209
Uterine Cervical Neoplasms93
Papillomavirus Infections25
Precancerous Conditions20
Squamous Intraepithelial Lesions12
Acquired Immunodeficiency Syndrome8
Neoplasms6
Atypical Squamous Cells of the Cervix5
HIV Infections5
Persistent Infection5

Trials

Showing 51 to 75 of 209. Each trial links to its page on Pharma Observatory.

109 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.